Precedence Research recently published a report on “Cell Lysis & Disruption Market (By Product: Instruments and Reagents; By Cell Type: Bacteria Cells, Mammalian Cells, Plant Cells, and Yeast/Fungi/Algae; By Application: Cell Organelle Isolation, Protein Isolation, Downstream Processing, and Nucleic Acid Isolation; By End Use: Hospitals and Diagnostic Laboratories, Cell Banks, Academic and Research Institutions, and Pharma & Biotechnology Companies) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030”, The global Cell Lysis & Disruption Market market size is projected to reach USD 7.1 billion by 2030 from an estimated USD 3.7 billion in 2020, at a CAGR of 6.7% from 2021 – 2030.
The market revenue/volume with the help of widespread quantitative and qualitative insights, and forecasts of the market. This report presents breakdown of market into forthcoming and niche segments. Additionally, this research study gauges market revenue growth and its drift at global, regional, and country from 2017 to 2030. This research report evaluates Cell Lysis & Disruption Market market on a global and regional level. It offers thorough analysis of market status, growth and forecast of the global Cell Lysis & Disruption Market market for the period from 2017 to 2030.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1292
Crucial factors accountable for market growth are:
Regional Snapshots
North America dominated the global cell lysis & disruption market in 2020 and is expected to retain its dominance during the forecast period. This is attributed to the existence of huge number of research organizations coupled increased investments by the private players for the research and development of various biopharmaceutical products. According to the Pharmaceutical Research and Manufacturers Association, around US$ 80 billion was invested in the research & development of biopharmaceuticals in 2018 in US. Moreover, the US holds around one-third of the global biopharmaceutical market and hence with the growth of the biopharmaceutical industry in US, the cell lysis and disruption market in North America is also anticipated to grow at a rapid pace. Moreover, growing prevalence of chronic disease along with the growing geriatric population and rising adoption of cell therapies is positively boosting the demand for the cell lysis technology in the region.
On the other hand, the Asia Pacific is expected to be the fastest-growing cell lysis and disruption market during the forecast period. The demand for the cell therapy for cancer treatment is gaining rapid traction in the markets such as China, Japan, and South Korea, which is augmenting the market growth. Further, the rising investments in the region for the development of the biologic industry are expected to significantly fuel the market growth during the forecast period.
Market Dynamics
Drivers – The cell lysis & disruption market is primarily driven by the growing demand for the cell disruption technology and rising adoption of mammalian cell in the cell lysis industry. Further the rapid growth of the cell therapies and gene therapies owing to the growing preferences of the people in treatment of various chronic diseases is significantly boosting the market growth.
Restraints – The major retraining factors include high costs of the equipment used in the cell lysis & disruption and lack of skilled professionals. These are the major restraints that may hamper the market growth in the upcoming years. Moreover, the cell-based researches involve high costs and are a key restraint.
Opportunity – The emerging markets such as China, South Korea, India, and Brazil offers lucrative growth opportunities to the market players owing to the rising prevalence of various chronic disease, huge government expenditure in building healthcare infrastructure for facilitating research activities, and increasing penetration of research laboratories funded by the private players.
Challenges – The high costs involved may restrict the new entrants in the market and make the survival of the small players difficult. For surviving in the market, the players need to reduce their operational costs in order to focus on the research activities, which is very difficult for the small players in the market.
Report Highlights
Scope of the Study
This Cell Lysis & Disruption Market market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This research report offers scenario and forecast (revenue/volume), and categorizes market by players, type, application, and region. This report also studies global market prominence, competitive landscape, market share, growth rate market dynamics such as drivers, restraints and opportunities, and distributors and sales channel.
This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers competitive scenario which comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
Key Players:
This report also provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Cell Lysis & Disruption Market market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Some of the prominent players in the Cell Lysis & Disruption Market market include:
Segments Covered in the Report
By Product
By Cell Type
By Application
By End Use
By Geography
Key Points Covered in Cell Lysis & Disruption Market market Study:
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cell Lysis & Disruption Market, By Product
7.1. Cell Lysis & Disruption Market, by Product Type, 2021-2030
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Reagents
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Cell Lysis & Disruption Market, By Application
8.1. Cell Lysis & Disruption Market, by Application, 2021-2030
8.1.1. Cell Organelle Isolation
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Protein Isolation
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Downstream Processing
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Nucleic Acid Isolation
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell Lysis & Disruption Market, By Cell Type
9.1. Cell Lysis & Disruption Market, by Cell Type, 2021-2030
9.1.1. Bacteria Cells
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Mammalian Cells
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Plant Cells
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Yeast/Fungi/Algae
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell Lysis & Disruption Market, By End Use Type
10.1. Cell Lysis & Disruption Market, by End Use Type, 2021-2030
10.1.1. End Use
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Cell Banks
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Academic and Research Institutions
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Pharma & Biotechnology Companies
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell Lysis & Disruption Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End Use Type (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Cell Type (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End Use Type (2017-2030)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Danaher Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Qiagen NV
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Parr Instrument Company
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Covaris Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Merck KGaA
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. F. Hoffmann-La Roche Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Claremont BioSolutions
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Becton Dickinson & Company
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1292
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://precedenceresearchnews.wordpress.com
Follow us on LinkedIn | Twitter | Facebook
Precedence Research recently published a report on “Drug of Abuse Testing Market (By Drug Type: Alcohol, Cocaine, Marijuana/Cannabis, LSD, Opioids,… Read More
Precedence Research recently published a report on “Digital Signage Market (By Component: Hardware, Software, Services; By Technology: LCD, LED, Projection;… Read More
Precedence Research recently published a report on “Beverage Packaging Market (By Material: Metal, Plastic, Glass, and Others; By Product: Bottles,… Read More
Precedence Research recently published a report on “Paper Cups Market (By type: Hot Paper Cups and Cold Paper Cups; By… Read More
Precedence Research recently published a report on “Fire Protection System Market (By Product: Fire Detection, Fire Suppression, Fire Response, Fire… Read More
This website uses cookies.